Home » Topics » Infection » HIV/AIDS

HIV/AIDS
RSS

Safety of anti-HIV PRO-2000 vaginal gel shown in healthy women

Aug. 24, 2005

Safety, tolerability and antiviral efficacy of GW-695634 in NNRTI-resistant HIV-1-infected patients

Aug. 23, 2005

Antiretroviral efficacy of stampidine is evident in FIV-infected cats

Aug. 23, 2005

WHI-07 alone or in combination with vanadocene protects cats from FIV

Aug. 22, 2005

Combination of microbicides CAP and UC-781 synergistically inhibits HIV-1 replication

Aug. 22, 2005

Thiovir effective against resistant HIV-1 strains and synergistic with zidovudine

Aug. 18, 2005

Antiviral efficacy and pharmacokinetics of vicriviroc alone or in combination with other antivirals

Aug. 18, 2005

Antiviral efficacy and pharmacokinetics of single-oral dose PA-457 reported in HIV-infected patients

Aug. 18, 2005

Bioequivalence studies continue for fixed-dose Truvada/Sustiva product

Aug. 16, 2005

New anti-HIV agents described in recent Pfizer patent

Aug. 10, 2005

Popular Stories

Today's news in brief
BioWorld
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...